ESCI期刊Clinical and Experimental Vaccine Research 2024/2025影响因子:2.199 (CLIN EXP VACCINE RES) (2287-3651). (IMMUNOLOGY)(免

显示全部楼层 · 发表于 2025-3-27 01:56:14

Submitted on: 10 January 2007. Revised on: 20 April 2007. Accepted on: 25 May 2007. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-27 09:18:14

Submitted on: 08 December 2020. Revised on: 22 February 2021. Accepted on: 18 April 2021. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-27 09:38:45

Submitted on: 22 July 2011. Revised on: 30 October 2011. Accepted on: 21 November 2011. ___________________Clinical and Experimental Vaccine Research

显示全部楼层 · 发表于 2025-3-27 14:00:17

显示全部楼层 · 发表于 2025-3-27 19:13:38

		自动登录	找回密码
密码			To register

关于派博传思			派博传思旗下网站			友情链接
派博传思介绍	公司地理位置	论文服务流程	影响因子官网	SITEMAP	大讲堂	北京大学	Oxford Uni.	Harvard Uni.
发展历史沿革	期刊点评	投稿经验总结	SCIENCEGARD	IMPACTFACTOR	派博系数	清华大学	Yale Uni.	Stanford Uni.
\|Archiver\|手机版\|小黑屋\| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-4-27 16:19
Copyright © 2001-2015 派博传思京公网安备110108008328 版权所有 All rights reserved

ESCI期刊Clinical and Experimental Vaccine Research 2024/2025影响因子:2.199 (CLIN EXP VACCINE RES) (2287-3651). (IMMUNOLOGY)(免

浏览过的版块